- $78.71m
- $88.70m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.463 | 0.559 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 20.7 | 29.5 | 36.2 | 36.1 | 31.5 |
Operating Profit | -20.2 | -29 | -36.2 | -36.1 | -31.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -22.1 | -30.3 | -36.4 | -36.7 | -32.2 |
Net Income After Taxes | -22.1 | -30.3 | -36.4 | -36.7 | -32.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -22.1 | -30.3 | -36.4 | -36.7 | -32.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.1 | -30.3 | -36.7 | -37.6 | -32.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.71 | -0.824 | -0.903 | -0.872 | -0.728 |